Tag : CONTINUOUS GLUCOSE MONITORING (CGM)

  • Prediabetes poses a substantial clinical burden, particularly in the Asia-Pacific region. Continuous glucose monitoring (CGM), wearable technologies, and artificial intelligence (AI) can support earlier detection, refined risk stratification, and personalized lifestyle interventions, helping address limitations of traditional type 2 diabetes (T2D) prevention programs.

    doctor name

    Dr. Chow, Yee-Kwan Elaine

    Clinical Assistant Professor, Department of Medicine & Therapeutics Deputy Medical Director, Phase 1 Clinical Trial Centre, The Chinese University of Hong Kong